<VariationArchive VariationID="554880" VariationName="NM_000053.4(ATP7B):c.111dup (p.Ala38fs)" VariationType="Duplication" Accession="VCV000554880" Version="8" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-23" DateCreated="2018-08-05" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="547406" VariationID="554880">
      <GeneList>
        <Gene Symbol="ATP7B" FullName="ATPase copper transporting beta" GeneID="540" HGNC_ID="HGNC:870" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="51932669" stop="52012132" display_start="51932669" display_stop="52012132" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="52506804" stop="52585629" display_start="52506804" display_stop="52585629" Strand="-" />
          </Location>
          <OMIM>606882</OMIM>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000053.4(ATP7B):c.111dup (p.Ala38fs)</Name>
      <CanonicalSPDI>NC_000013.11:51975108:AAAA:AAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>13q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="51975108" stop="51975109" display_start="51975108" display_stop="51975109" variantLength="1" positionVCF="51975108" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="52549244" stop="52549245" display_start="52549244" display_stop="52549245" variantLength="1" positionVCF="52549244" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>A38fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.52549248dup" Assembly="GRCh37">
            <Expression>NC_000013.10:g.52549248dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.51975112dup" Assembly="GRCh38">
            <Expression>NC_000013.11:g.51975112dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008806.1" sequenceAccession="NG_008806" sequenceVersion="1" change="g.41386dup">
            <Expression>NG_008806.1:g.41386dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000053.4" sequenceAccession="NM_000053" sequenceVersion="4" change="c.111dup" MANESelect="true">
            <Expression>NM_000053.4:c.111dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000044.2" sequenceAccession="NP_000044" sequenceVersion="2" change="p.Ala38fs">
            <Expression>NP_000044.2:p.Ala38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001005918.3" sequenceAccession="NM_001005918" sequenceVersion="3" change="c.111dup">
            <Expression>NM_001005918.3:c.111dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001005918.1" sequenceAccession="NP_001005918" sequenceVersion="1" change="p.Ala38fs">
            <Expression>NP_001005918.1:p.Ala38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001243182.2" sequenceAccession="NM_001243182" sequenceVersion="2" change="c.111dup">
            <Expression>NM_001243182.2:c.111dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001230111.1" sequenceAccession="NP_001230111" sequenceVersion="1" change="p.Ala38fs">
            <Expression>NP_001230111.1:p.Ala38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330578.2" sequenceAccession="NM_001330578" sequenceVersion="2" change="c.111dup">
            <Expression>NM_001330578.2:c.111dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317507.1" sequenceAccession="NP_001317507" sequenceVersion="1" change="p.Ala38fs">
            <Expression>NP_001317507.1:p.Ala38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330579.2" sequenceAccession="NM_001330579" sequenceVersion="2" change="c.111dup">
            <Expression>NM_001330579.2:c.111dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317508.1" sequenceAccession="NP_001317508" sequenceVersion="1" change="p.Ala38fs">
            <Expression>NP_001317508.1:p.Ala38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000053.3" sequenceAccession="NM_000053" sequenceVersion="3" change="c.111dupT">
            <Expression>NM_000053.3:c.111dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1555296939" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000053.4(ATP7B):c.111dup (p.Ala38fs) AND Wilson disease" Accession="RCV000670588" Version="9">
        <ClassifiedConditionList TraitSetID="1056">
          <ClassifiedCondition DB="MedGen" ID="C0019202">Wilson disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-03" SubmissionCount="6">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-03" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2018-08-05" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23518715</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1056" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6125" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hepatolenticular degeneration</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wilson disease</ElementValue>
                <XRef ID="MONDO:0010200" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wilson's disease</ElementValue>
                <XRef ID="Wilson+disease/7506" DB="Genetic Alliance" />
                <XRef ID="88518009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WND</ElementValue>
                <XRef Type="MIM" ID="277900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WD</ElementValue>
                <XRef Type="MIM" ID="277900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Wilson disease is a disorder of copper metabolism that can present with hepatic, neurologic, or psychiatric disturbances, or a combination of these, in individuals ranging from age three years to older than 50 years; symptoms vary among and within families. Liver disease includes recurrent jaundice, simple acute self-limited hepatitis-like illness, autoimmune-type hepatitis, fulminant hepatic failure, or chronic liver disease. Neurologic presentations include movement disorders (tremors, poor coordination, loss of fine-motor control, chorea, choreoathetosis) or rigid dystonia (mask-like facies, rigidity, gait disturbance, pseudobulbar involvement). Psychiatric disturbance includes depression, neurotic behaviors, disorganization of personality, and, occasionally, intellectual deterioration. Kayser-Fleischer rings, frequently present, result from copper deposition in Descemet's membrane of the cornea and reflect a high degree of copper storage in the body.</Attribute>
                <XRef ID="NBK1512" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7893" />
                <XRef ID="7893" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000567667" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529392" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528928" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529414" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000503091" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530097" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509712" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515523" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520058" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501125" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530035" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553937" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552345" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521900" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260623" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507952" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528632" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301685</ID>
                <ID Source="BookShelf">NBK1512</ID>
              </Citation>
              <Citation Type="general" Abbrev="AASLD, 2008">
                <ID Source="PubMed">18506894</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="905" DB="Orphanet" />
              <XRef ID="C0019202" DB="MedGen" />
              <XRef ID="MONDO:0010200" DB="MONDO" />
              <XRef Type="MIM" ID="277900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1545761" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="239728|OMIM:277900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000795458" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23518715</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP7B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="CA" referenceAllele="C" start="52549244" stop="52549244" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000053.3:c.111dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3868227" SubmissionDate="2021-10-12" DateLastUpdated="2021-10-16" DateCreated="2021-10-16">
        <ClinVarSubmissionID localKey="NM_000053.4:c.111dup|OMIM:277900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001977413" DateUpdated="2021-10-16" DateCreated="2021-10-16" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP7B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000053.4:c.111dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10430414</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4065252" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-12" DateCreated="2022-02-12">
        <ClinVarSubmissionID localKey="NM_000053.3:c.111dupT|MedGen:C0019202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002074232" DateUpdated="2022-02-12" DateCreated="2022-02-12" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23518715</ID>
          </Citation>
          <Comment>Variant summary: ATP7B c.111dupT (p.Ala38CysfsX3) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 249446 control chromosomes (gnomAD). c.111dupT has been reported in the literature in individuals affected with Wilson Disease (Coffey_2013). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP7B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000053.3:c.111dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0019202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11058952</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5415262" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000053_3_ATP7B_c_111dupT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768650" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A heterozygous frameshift duplication variant, NM_000053.3(ATP7B):c.111dupT, has been identified in exon 2 of 21 of the ATP7B gene. This duplication is predicted to create a frameshift starting at amino acid position 38, introducing a stop codon 3 residues downstream (NP_000044.2(ATP7B):p.Ala38Cysfs*3). This variant is predicted to result in loss of protein function either through nonsense-mediated decay, which is a reported mechanism of pathogenicity for this gene. The variant is present in the gnomAD database at a frequency of 0.00040% (1 heterozygote, 0 homozygotes). The variant has been previously described as pathogenic and reported in a patient with Wilson's disease (ClinVar, Coffey, A. J., et al. (2013)). Many up- and downstream variants also resulting in a premature termination codon have been reported in patients with Wilson's disease (ClinVar). Based on the information available at the time of curation, this variant has been classified as PATHOGENIC.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP7B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_418</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000053.3:c.111dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7860765" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000053.4:c.111dup|OMIM:277900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004216368" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000053.4:c.111dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9056095" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="101372064|Orphanet:ORPHA905" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848413" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23518715</ID>
          </Citation>
          <Comment>The p.Ala38CysfsX3 variant in ATP7B has been previously reported in 2 individuals with Wilson disease who were compound heterozygous for two different known pathogenic ATP7B variants (p.Asn1270Ser and p.His1069Gln) (PMID 23518715). It has been reported in ClinVar by a clinical laboratory (Variation ID 554880). This variant has also been identified in 0.0008% (1/113170) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 38 and leads to a premature termination codon 3 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the ATP7B gene is an established disease mechanism in autosomal recessive Wilson disease. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Wilson disease. ACMG/AMP Criteria applied: PVS1, PM2, PM3, PP4.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP7B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000053.4:exon 2A</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.11:g.51975108_51975109insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA905" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1545761" TraitType="Disease" MappingType="XRef" MappingValue="277900" MappingRef="OMIM">
        <MedGen CUI="C0019202" Name="Wilson disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9056095" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA905" MappingRef="Orphanet">
        <MedGen CUI="C0019202" Name="Wilson disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3868227" TraitType="Disease" MappingType="XRef" MappingValue="277900" MappingRef="OMIM">
        <MedGen CUI="C0019202" Name="Wilson disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7860765" TraitType="Disease" MappingType="XRef" MappingValue="277900" MappingRef="OMIM">
        <MedGen CUI="C0019202" Name="Wilson disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4065252" TraitType="Disease" MappingType="XRef" MappingValue="C0019202" MappingRef="MedGen">
        <MedGen CUI="C0019202" Name="Wilson disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5415262" TraitType="Disease" MappingType="XRef" MappingValue="277900" MappingRef="OMIM">
        <MedGen CUI="C0019202" Name="Wilson disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

